Figure 6From: Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors The cumulative overall survival (OS) of patients with high soluble N-cadherin (sN-CAD) levels, compared to patients with low sN-CAD levels. Back to article page